Cabergoline 0.5mgTablet
Steroids & Hormonal

Cabergoline 0.5mg

Cabergoline

Long-acting ergot-derived dopamine D2 agonist that normalizes serum prolactin and reduces prolactinoma size with twice-weekly dosing, offering superior tolerability over older dopamine agonists. Exported by Sun Pharma and Cipla for endocrinology and neurology markets in applications covering hyperprolactinemia, lactation inhibition, and adjunct Parkinson's therapy.

Strengths

0.25mg / 0.5mg

Packing

4 tablets/strip

Origin

India (WHO-GMP)

MOQ

100 units

Export Price

On Request

Availability

In Stock

Quotation with pricing, availability, and shipping timeline sent within 24 hours.

Product Specifications

Composition
Cabergoline 0.25mg / 0.5mg
Dosage Form
Tablet
Available Strengths
0.25mg / 0.5mg
Packing
4 tablets/strip
Route of Administration
Oral, with or without food
Dosage
0.25mg twice weekly initially; increase by 0.25mg at 4-week intervals; usual dose 0.5-1mg/week
Indications
Hyperprolactinemia (idiopathic or pituitary adenoma), inhibition of lactation, Parkinson's disease (high dose)
Country of Origin
India (WHO-GMP Certified)
Storage
Store at 20-25°C
Shelf Life
36 months
Side Effects
Nausea, headache, dizziness, constipation, fatigue, orthostatic hypotension, nasal congestion
Precautions
Risk of cardiac valvulopathy at high doses (Parkinson's); echocardiography before and during long-term use; impulse control disorders; avoid in hepatic impairment; may impair driving

Disclaimer: This information is intended for healthcare professionals and international pharmaceutical buyers only. Product availability, registration status, and approved indications may vary by country. All products are supplied with Certificate of Analysis (CoA), commercial invoice, and packing list. Rx products require valid prescription in the destination country.

Need bulk pricing for Cabergoline 0.5mg?

Send us your quantity requirements and destination country for a custom quotation.

Get Bulk Quote